The Bionics Institute went “purple” in support of awareness for epilepsy.
Epilepsy is a common neurological disorder that affects approximately two percent of the population in Australia, this equates to nearly half a million people.
Patients with undiagnosed seizures or difficulties with drug therapy face ongoing stress, risks and uncertainty when carrying out their normal daily activities. To address this clinical need, the Bionics Institute has pioneered a small bionic device, implanted under the scalp, to monitor the brain’s electrical activity over extended periods of time.
Learn more about our Epilepsy research